ATE197052T1 - Topiramate-immunoassay, sowie analoge und antikörper - Google Patents

Topiramate-immunoassay, sowie analoge und antikörper

Info

Publication number
ATE197052T1
ATE197052T1 AT96942815T AT96942815T ATE197052T1 AT E197052 T1 ATE197052 T1 AT E197052T1 AT 96942815 T AT96942815 T AT 96942815T AT 96942815 T AT96942815 T AT 96942815T AT E197052 T1 ATE197052 T1 AT E197052T1
Authority
AT
Austria
Prior art keywords
topiramate
immunoassay
antibodies
analogues
add
Prior art date
Application number
AT96942815T
Other languages
English (en)
Inventor
Kenneth J Stenglein
Daniel B Cawley
Bruce E Maryanoff
Kirk L Sorgi
Original Assignee
Opus Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24257371&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE197052(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Opus Diagnostics Inc filed Critical Opus Diagnostics Inc
Application granted granted Critical
Publication of ATE197052T1 publication Critical patent/ATE197052T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04—Cyclic acetals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9473—Anticonvulsants, e.g. phenobarbitol, phenytoin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
AT96942815T 1995-12-01 1996-11-27 Topiramate-immunoassay, sowie analoge und antikörper ATE197052T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/565,143 US5952187A (en) 1995-12-01 1995-12-01 Topiramate immunoassay
PCT/US1996/018971 WO1997019950A1 (en) 1995-12-01 1996-11-27 Topiramate immunoassay, as well as analogs and antibodies

Publications (1)

Publication Number Publication Date
ATE197052T1 true ATE197052T1 (de) 2000-11-15

Family

ID=24257371

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96942815T ATE197052T1 (de) 1995-12-01 1996-11-27 Topiramate-immunoassay, sowie analoge und antikörper

Country Status (9)

Country Link
US (1) US5952187A (de)
EP (1) EP0876385B1 (de)
JP (1) JP4435305B2 (de)
AT (1) ATE197052T1 (de)
AU (1) AU721665B2 (de)
CA (1) CA2239224C (de)
DE (1) DE69610716T2 (de)
ES (1) ES2153134T3 (de)
WO (1) WO1997019950A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0019593D0 (en) * 2000-08-10 2000-09-27 Norgine Europe Bv Production of bile acid derivatives
UA78211C2 (en) * 2001-07-09 2007-03-15 Ortho Mcneil Pharm Inc Salts of fructopyranose derivatives as anticonvulsant
ES2292787T3 (es) 2001-07-13 2008-03-16 Diachemix Llc Ensayo homogeneo basado en la polimerizacion de fluorescencia para las aflatoxinas.
US20100311701A1 (en) * 2002-02-15 2010-12-09 Transform Pharmaceuticals, Inc Pharmaceutical Co-Crystal Compositions
US7790905B2 (en) * 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
US7927613B2 (en) 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
US20090088443A1 (en) * 2002-02-15 2009-04-02 Julius Remenar Novel crystalline forms of conazoles and methods of making and using the same
US6559293B1 (en) * 2002-02-15 2003-05-06 Transform Pharmaceuticals, Inc. Topiramate sodium trihydrate
IL163846A0 (en) 2002-03-01 2005-12-18 Univ South Florida Multiple-component solid phases containing at least one active pharmaceutical ingredient
US7060725B2 (en) * 2002-05-13 2006-06-13 Janssen Pharmaceutica N.V. Substituted sulfamate anticonvulsant derivatives
US20070059356A1 (en) * 2002-05-31 2007-03-15 Almarsson Oern Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
CN100360117C (zh) * 2002-06-21 2008-01-09 转化医药公司 具有提高的溶出度的药物组合物
US8183290B2 (en) 2002-12-30 2012-05-22 Mcneil-Ppc, Inc. Pharmaceutically acceptable propylene glycol solvate of naproxen
WO2005088307A1 (en) * 2004-03-10 2005-09-22 Seradyn Inc. Immunoassays for everolimus
US20060088886A1 (en) * 2004-10-25 2006-04-27 Anlong Ouyang Topiramate analogs
US7638291B2 (en) 2004-10-25 2009-12-29 Seradyn, Inc. Immunoassays for topiramate
US20090239942A1 (en) 2006-09-15 2009-09-24 Cloyd James C Topiramate Compositions and Methods of Making and Using the Same
PT2061458E (pt) * 2006-09-15 2015-03-11 Univ Minnesota Composições de topiramato e métodos para a sua utilização
EP2261259B1 (de) * 2009-06-10 2014-07-30 Randox Laboratories Ltd. Immunoassay für N-(3-chlorphenyl)piperazin-basierte Antidepressiva
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
CN110655542A (zh) * 2018-06-29 2020-01-07 鲁南制药集团股份有限公司 一种2,3:4,5-双-O-(1-甲基亚乙基)-β-D-吡喃果糖氯磺酸酯的晶型
CN114685526A (zh) * 2020-12-25 2022-07-01 长沙博源医疗科技有限公司 一种托吡酯衍生物、免疫原、抗托吡酯特异性抗体及其制备方法与应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU555213B2 (en) * 1981-02-17 1986-09-18 Abbott Laboratories N-substituted-amido-fluoresein derivatives
US4668640A (en) * 1981-12-11 1987-05-26 Abbott Laboratories Fluorescence polarization immunoassay utilizing substituted carboxyfluoresceins
US4492762A (en) * 1981-12-11 1985-01-08 Abbott Laboratories Fluorescent polarization immunoassays
EP0218010A3 (de) * 1985-07-10 1988-01-07 Abbott Laboratories Verfahren zur Bestimmung von Liganden und substituierte Carboxyfluoreszein-Markers zur Durchführung desselben
US4751190A (en) * 1985-07-22 1988-06-14 Abbott Laboratories Fluorescence polarization immunoassay and reagents for use therein
US5051361A (en) * 1988-10-19 1991-09-24 Sigma Chemical Company AZT immunoassays, derivatives, conjugates and antibodies
US5258402A (en) * 1992-06-11 1993-11-02 Mcneil-Ppc, Inc. Imidate derivatives of pharmaceutically useful anticonvulsant sulfamates
US5384327A (en) * 1992-12-22 1995-01-24 Mcneilab, Inc. Anticonvulsant sorbopyranose sulfamates

Also Published As

Publication number Publication date
AU1141697A (en) 1997-06-19
CA2239224C (en) 2006-11-14
JP2000502888A (ja) 2000-03-14
ES2153134T3 (es) 2001-02-16
DE69610716T2 (de) 2001-05-10
AU721665B2 (en) 2000-07-13
DE69610716D1 (de) 2000-11-23
EP0876385A1 (de) 1998-11-11
US5952187A (en) 1999-09-14
EP0876385B1 (de) 2000-10-18
JP4435305B2 (ja) 2010-03-17
CA2239224A1 (en) 1997-06-05
WO1997019950A1 (en) 1997-06-05

Similar Documents

Publication Publication Date Title
ATE197052T1 (de) Topiramate-immunoassay, sowie analoge und antikörper
DK261386A (da) Monoklonale antistoffer
ATE161289T1 (de) Repamycinbestimmung
MY104946A (en) Antigen antibody conjugate.
EP0674178A3 (de) Cyclosporin-Immunoassay.
ATE112059T1 (de) Verfahren zur bestimmung eines analyten.
CA2172663A1 (en) Improved reagents for a cannabinoid immunoassay
AR022890A1 (es) Citoquinas mamiferas; reactivos relacionados y metodos
GB9719357D0 (en) Immunoassay Utilizing Two Incubations With Labelled Antigen
DE69839876D1 (de) Prostat-spezifisches-antigenformen und verfahren zu ihrer bestimmung
ES2126597T3 (es) Sistema de sondas que permite efectuar la tipificacion hla dr, y procedimiento de tipificacion que utiliza dichas sondas.
ES8501530A1 (es) Metodo de ensayo de anticuerpos.
ATE294237T1 (de) S?ugetier thymokingene
EP0613899A3 (de) Kokainderivat, sein Proteinkonjugat, monoklonale Antikörper produzierende Zellinie, Verfahren zur Herstellung der Zellinie und monoklonale Antikörper.
ATE154395T1 (de) Monoklonale antikörper
FI86255B (fi) Monoklonal antiurokinase-antikropp, den innehaollande matris och biokemiska testpackningar, i vilka den anvaendes.
FR2599513B1 (fr) Anticorps monoclonaux inhibant la liaison de ige soluble aux lymphocytes humains, hybridomes monoclonaux produisant de tels anticorps, leur utilisation
DE69922680D1 (de) Detektion und quantifikation von vancomycin in den biologischen flüssigkeiten
MX9704717A (es) Antigeno, anticuerpos y ensayo de diagnostico para la enfermedad de alzheimer.
HUP9701386A2 (hu) Immunológiai vizsgálati eljárás
JPS5386014A (en) Quantitative analysis of antigen and antibody
DK0964875T3 (da) Antistof specifikt for 5-hydroxytryptophol eller et konjugat deraf samt immunoassay til bestemmelse af 5-hydroxytryptophol eller konjugater deraf
AU5801196A (en) Relaxin diagnostic assays and kits, and methods and uses thereof
DE59913439D1 (de) Anti-petasin-antikörper, verfahren zu ihrer herstellung und ihre verwendung
AU5178090A (en) Monoclonal antibody, and assay method, reagent kit, search method and drug missile using said antibody

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties